Results for
"[search-keyword]"
Sponsor content
49 result(s) found, displaying 21 to 30
-
Cancellation by sponsorRequested by Celltrion Healthcare Australia Pty Ltd
-
Cancellation by sponsorRequested by Celltrion Healthcare Australia Pty Ltd
-
Cancellation by sponsorRequested by Celltrion Healthcare Australia Pty Ltd
-
Cancellation by sponsorRequested by Celltrion Healthcare Australia Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YUFLYMA adalimumab (rch) 40 mg/0.4 mL solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YUFLYMA adalimumab (rch) 40 mg/0.4 mL solution for injection pre-filled syringe in autoinjector.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for YUFLYMA adalimumab (rch) 40 mg/0.4 mL solution for injection pre-filled syringe with a safety guard.
-
Australian Public Assessment Report (AusPAR)AusPAR for Yuflyma (adalimumab) for the treatment of rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis etc.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Celltrion Healthcare Australia Pty Ltd - Skin-cleaning wipe, sterile.
-
Prescription medicine decision summaryTGA Decision: Yuflyma (adalimumab) is approved to treat multiple auto-immune conditions.